Defining persistent fatigue as patient-reported presence of moderate or greater fatigue, the purpose of this study was to examine the factors associated with persistent fatigue in patients with established RA despite demonstrating a good disease response to 6 months of tumour necrosis factor (TNF) inhibitor therapy. Here, TNF is linked to rheumatoid arthritis.